Biochemistry of SAMHD1-mediated innate immunity responses

SAMHD1 介导的先天免疫反应的生物化学

基本信息

项目摘要

ABSTRACT SAMHD1, a mammalian member of the HD-domain hydrolase family of enzymes, catalyzes hydrolysis of deoxynucleotides triphosphates (dNTPs) to triphosphate and unphosphorylated nucleosides, which is thought to be the main pathway for controlled depletion of cellular dNTPs. Discoveries that SAMHD1 is an immune factor that restricts retroviral replication in non-cycling immune cells and regulates interferon signaling revealed that dNTP depletion may act as a defense mechanism of innate antiviral immunity. Existence of such mechanism implies that the enzymatic activity of SAMHD1 must be controlled by pathways of innate immune sensing and response, and that cellular regulation of SAMHD1 is key to understanding the functional relationship between antiviral immunity and dNTP metabolism. In the studies described here we will use unique experimental tools developed by my laboratory to elucidate how biochemical regulation of SAMHD1 determines its immune function. This project will explore two novel regulatory mechanisms that have emerged from our preliminary work and establish their contribution to the SAMHD1-mediated anti-retroviral state in non- cycling immune cells. The studies will shed light on how and possibly why different molecular clues and cellular signaling pathways alter susceptibility of myeloid and resting T cells to HIV infection, and thus elucidate the biological significance of SAMHD1 function at the interface of dNTP metabolism and antiviral defense. In a continued collaboration with the laboratory of Dr. Diaz-Griffero we will pursue two major specific aims. In Aim 1 we will explore the role of nucleic acid binding in the immune function of SAMHD1, elucidate structural and biochemical determinants of high-affinity interaction of SAMHD1 with oligonucleotides and determine what nucleic acid species regulate SAMHD1 activity and why. Our preliminary data suggest that phosphorothioate linkages in nucleic acids may act as a danger-associated molecular pattern or a second messenger in antiviral immunity. In Aim 2 we will elucidate the mechanism linking redox transformations of SAMHD1 to the enzymatic activity and the immune function of the protein. Our preliminary studies suggest that redox regulation of SAMHD1 may offer insight into the emerging role of reactive oxygen species (ROS) in modulating innate antiviral immunity. We will determine what redox states are sampled by the redox-active cysteines of SAMHD1, how these transformations alter the biochemical properties of the protein and explore whether SAMHD1 activity is controlled by specific sources of ROS and signaling pathways in the cell.
摘要 SAMHD 1是HD结构域水解酶家族的哺乳动物成员,催化 脱氧核苷酸三磷酸(dNTPs)三磷酸和非磷酸化核苷,这被认为是 是细胞dNTPs受控耗竭的主要途径。发现SAMHD 1是一种免疫 一种限制非循环免疫细胞中逆转录病毒复制并调节干扰素信号传导的因子 dNTP缺失可能是先天性抗病毒免疫的防御机制。存在这种 这一机制表明SAMHD 1的酶活性必须由先天免疫途径控制, SAMHD 1的细胞调节是理解细胞功能的关键。 抗病毒免疫与dNTP代谢的关系。在这里描述的研究中,我们将使用 我的实验室开发了独特的实验工具,以阐明SAMHD 1的生化调节 决定其免疫功能。本项目将探索两种新的监管机制, 从我们的初步工作,并建立他们的贡献,SAMHD 1介导的抗逆转录病毒状态的非- 循环免疫细胞这些研究将阐明不同的分子线索和细胞的 信号通路改变了髓样和静息T细胞对HIV感染的易感性,从而阐明了 SAMHD 1在dNTP代谢和抗病毒防御界面功能的生物学意义。中 继续与Diaz-Griffero博士的实验室合作,我们将追求两个主要的具体目标。目标1 我们将探索核酸结合在SAMHD 1免疫功能中的作用,阐明SAMHD 1的结构和功能, SAMHD 1与寡核苷酸的高亲和力相互作用的生物化学决定因素,并确定 核酸种类调节SAMHD 1活性及其原因。我们的初步数据表明硫代磷酸酯 核酸中的连接可以作为一种与抗病毒相关的分子模式或第二信使, 免疫力在目标2中,我们将阐明SAMHD 1的氧化还原转化与酶促转化之间的联系机制。 活性和免疫功能。我们的初步研究表明, SAMHD 1可能提供了对活性氧(ROS)在调节先天性巨噬细胞中的新作用的认识。 抗病毒免疫我们将确定SAMHD 1的氧化还原活性半胱氨酸采样的氧化还原状态, 这些转化如何改变蛋白质的生化特性,并探索SAMHD 1 活性由细胞中特定的活性氧来源和信号传导途径控制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DMITRI N IVANOV其他文献

DMITRI N IVANOV的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DMITRI N IVANOV', 18)}}的其他基金

Biochemistry of SAMHD1-mediated innate immunity responses
SAMHD1 介导的先天免疫反应的生物化学
  • 批准号:
    10212922
  • 财政年份:
    2019
  • 资助金额:
    $ 46.78万
  • 项目类别:
Retroviral capsid recognition by TRIM5alpha restriction factors
TRIM5alpha 限制因子识别逆转录病毒衣壳
  • 批准号:
    9262531
  • 财政年份:
    2014
  • 资助金额:
    $ 46.78万
  • 项目类别:
Retroviral capsid recognition by TRIM5alpha restriction factors
TRIM5alpha 限制因子识别逆转录病毒衣壳
  • 批准号:
    8732420
  • 财政年份:
    2014
  • 资助金额:
    $ 46.78万
  • 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
  • 批准号:
    7898613
  • 财政年份:
    2009
  • 资助金额:
    $ 46.78万
  • 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
  • 批准号:
    7755507
  • 财政年份:
    2009
  • 资助金额:
    $ 46.78万
  • 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
  • 批准号:
    8055204
  • 财政年份:
    2009
  • 资助金额:
    $ 46.78万
  • 项目类别:
Capsid-mediated interactions in HIV assembly
HIV组装中衣壳介导的相互作用
  • 批准号:
    7230861
  • 财政年份:
    2007
  • 资助金额:
    $ 46.78万
  • 项目类别:
Capsid-mediated interactions in HIV assembly
HIV组装中衣壳介导的相互作用
  • 批准号:
    7364649
  • 财政年份:
    2007
  • 资助金额:
    $ 46.78万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 46.78万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了